Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 1846 AL 1860

Propranolol Reduces Parkinson's Tremor and Inhibits Tremor-Related Activity in the Motor Cortex: A Placebo-Controlled Crossover Trial

van der Heide A, Wessel M, Papadopetraki D, Geurts DEM, van Prooije TH, Gommans F, Bloem BR, Dirkx MF, Helmich RC.

Ann Neurol. 2025 Apr;97(4):741-752. doi: 10.1002/ana.27159. Epub 2024 Dec 21.

Dopaminergic Treatment and Episodic Memory in Parkinson's Disease: A Meta-analysis of the Literature

Stanzione A, Melchiori FM, Costa A, Leonardi C, Scalici F, Caltagirone C, Carlesimo GA.

Neuropsychol Rev. 2025 Dec;35(4):688-709. doi: 10.1007/s11065-024-09656-0. Epub 2024 Dec 21.

Advanced therapy in advanced Parkinson's disease: money's too tight to mention

Jost WH.

J Neural Transm (Vienna). 2025 Nov;132(11):1627-1628. doi: 10.1007/s00702-024-02871-2. Epub 2024 Dec 21.

Association between food insecurity and risk of Parkinson's disease: insights from NHANES data

Lu L.

J Nutr Health Aging. 2025 Mar;29(3):100464. doi: 10.1016/j.jnha.2024.100464. Epub 2024 Dec 20.

Psychiatric and cognitive symptoms of Parkinson's disease: A life's tale

Amstutz D, Sousa M, Maradan-Gachet ME, Debove I, Lhommée E, Krack P.

Rev Neurol (Paris). 2025 Apr;181(4):265-283. doi: 10.1016/j.neurol.2024.11.004. Epub 2024 Dec 22.

Comparison of cerebral technetium-99m-ethyl cysteinate dimer perfusion in patients with dementia with Lewy bodies and Parkinson's disease dementia

Toyli A, Hung GU, Zhao C, Sha Q, Chiu PY, Zhou W.

Nucl Med Commun. 2025 Mar 1;46(3):218-222. doi: 10.1097/MNM.0000000000001946. Epub 2024 Dec 23.

Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis

Canal-Garcia A, Branca RM, Francis PT, Ballard C, Winblad B, Lehtiö J, Nilsson P, Aarsland D, Pereira JB, Bereczki E.

Alzheimers Dement. 2025 Jan;21(1):e14375. doi: 10.1002/alz.14375. Epub 2024 Dec 23.

Co-expression-wide association studies link genetically regulated interactions with complex traits

Malakhov MM, Pan W.

medRxiv [Preprint]. 2025 Jun 23:2024.10.02.24314813. doi: 10.1101/2024.10.02.24314813.

Mechanisms and clinical applications of palmitoylethanolamide (PEA) in the treatment of neuropathic pain

Das A, Balakrishnan P.

Inflammopharmacology. 2025 Jan;33(1):121-133. doi: 10.1007/s10787-024-01623-8. Epub 2024 Dec 23.

The highs and lows of monoamine oxidase as molecular target in cancer: an updated review

Hâncu IM, Giuchici S, Furdui-Lința AV, Lolescu B, Sturza A, Muntean DM, Dănilă MD, Lighezan R.

Mol Cell Biochem. 2025 Jun;480(6):3225-3252. doi: 10.1007/s11010-024-05192-w. Epub 2024 Dec 23.

Probiotic: A Gut Microbiota-Based Therapeutic Approaches for the Treatment of Parkinson's Disease

Rout M, Prusty SK, Kar DM.

Curr Rev Clin Exp Pharmacol. 2025;20(4):322-333. doi: 10.2174/0127724328332572241219102122.

The design and development of LRRK2 inhibitors as novel therapeutics for Parkinson's disease

Bai X, Zhu J, Chen Y, Sun H.

Future Med Chem. 2025 Jan;17(2):221-236. doi: 10.1080/17568919.2024.2444875. Epub 2024 Dec 24.

Synaptic sabotage: How Tau and α-Synuclein undermine synaptic health

Uytterhoeven V, Verstreken P, Nachman E.

J Cell Biol. 2025 Feb 3;224(2):e202409104. doi: 10.1083/jcb.202409104. Epub 2024 Dec 24.

Microglial Depletion, a New Tool in Neuroinflammatory Disorders: Comparison of Pharmacological Inhibitors of the CSF-1R

Guenoun D, Blaise N, Sellam A, Roupret-Serzec J, Jacquens A, Steenwinckel JV, Gressens P, Bokobza C.

Glia. 2025 Apr;73(4):686-700. doi: 10.1002/glia.24664. Epub 2024 Dec 24.

The role of amphipathic and cationic helical peptides in Parkinson's disease

Pintado-Grima C, Ventura S.

Protein Sci. 2025 Jan;34(1):e70020. doi: 10.1002/pro.70020.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias